Literature DB >> 24176417

Clinical neurogenetics: amyotrophic lateral sclerosis.

Matthew B Harms1, Robert H Baloh.   

Abstract

Our understanding of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, is expanding rapidly as its genetic causes are uncovered. The pace of new gene discovery over the last 5 years has accelerated, providing new insights into the pathogenesis of disease and highlighting biological pathways as targets for therapeutic development. This article reviews our current understanding of the heritability of ALS and provides an overview of each of the major ALS genes, highlighting their phenotypic characteristics and frequencies as a guide for clinicians evaluating patients with ALS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; Amyotrophic lateral sclerosis; Genetics; Phenotypes

Mesh:

Year:  2013        PMID: 24176417      PMCID: PMC3815699          DOI: 10.1016/j.ncl.2013.05.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  185 in total

1.  Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.

Authors:  Stéphanie Millecamps; Philippe Corcia; Cécile Cazeneuve; Séverine Boillée; Danielle Seilhean; Véronique Danel-Brunaud; Nadia Vandenberghe; Pierre-François Pradat; Nadine Le Forestier; Lucette Lacomblez; Gaëlle Bruneteau; William Camu; Alexis Brice; Vincent Meininger; Eric LeGuern; François Salachas
Journal:  Neurobiol Aging       Date:  2011-12-09       Impact factor: 4.673

2.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Authors:  Adriano Chiò; Giuseppe Borghero; Maura Pugliatti; Anna Ticca; Andrea Calvo; Cristina Moglia; Roberto Mutani; Maura Brunetti; Irene Ossola; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Paola Cossu; Yevgeniya Abramzon; Janel O Johnson; Michael A Nalls; Sampath Arepalli; Sean Chong; Dena G Hernandez; Bryan J Traynor; Gabriella Restagno
Journal:  Arch Neurol       Date:  2011-01-10

3.  Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.

Authors:  Johannes Brettschneider; Vivianna M Van Deerlin; John L Robinson; Linda Kwong; Edward B Lee; Yousuf O Ali; Nathaniel Safren; Mervyn J Monteiro; Jon B Toledo; Lauren Elman; Leo McCluskey; David J Irwin; Murray Grossman; Laura Molina-Porcel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-03-18       Impact factor: 17.088

4.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.

Authors:  S G Lindquist; M Duno; M Batbayli; A Puschmann; H Braendgaard; S Mardosiene; K Svenstrup; L H Pinborg; K Vestergaard; L E Hjermind; J Stokholm; B B Andersen; P Johannsen; J E Nielsen
Journal:  Clin Genet       Date:  2012-07-04       Impact factor: 4.438

5.  Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Hajer El Oussini; Valérie Bercier; François Gros-Louis; Paul N Valdmanis; Jonathan McDearmid; Inge A Mejier; Patrick A Dion; Nicolas Dupre; David Hollinger; Jérome Sinniger; Sylvie Dirrig-Grosch; William Camu; Vincent Meininger; Jean-Philippe Loeffler; Frédérique René; Pierre Drapeau; Guy A Rouleau; Luc Dupuis
Journal:  Hum Mol Genet       Date:  2013-02-26       Impact factor: 6.150

6.  Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.

Authors:  Paul H Gordon; François Salachas; Lucette Lacomblez; Nadine Le Forestier; Pierre-François Pradat; Gaelle Bruneteau; Alexis Elbaz; Vincent Meininger
Journal:  Neurodegener Dis       Date:  2012-08-21       Impact factor: 2.977

7.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Authors:  Felix Geser; Maria Martinez-Lage; John Robinson; Kunihiro Uryu; Manuela Neumann; Nicholas J Brandmeir; Sharon X Xie; Linda K Kwong; Lauren Elman; Leo McCluskey; Chris M Clark; Joe Malunda; Bruce L Miller; Earl A Zimmerman; Jiang Qian; Vivianna Van Deerlin; Murray Grossman; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-02

8.  Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.

Authors:  Frank P Diekstra; Christiaan G J Saris; Wouter van Rheenen; Lude Franke; Ritsert C Jansen; Michael A van Es; Paul W J van Vught; Hylke M Blauw; Ewout J N Groen; Steve Horvath; Karol Estrada; Fernando Rivadeneira; Albert Hofman; Andre G Uitterlinden; Wim Robberecht; Peter M Andersen; Judith Melki; Vincent Meininger; Orla Hardiman; John E Landers; Robert H Brown; Aleksey Shatunov; Christopher E Shaw; P Nigel Leigh; Ammar Al-Chalabi; Roel A Ophoff; Leonard H van den Berg; Jan H Veldink
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

9.  Sporadic ALS is not associated with VAPB gene mutations in Southern Italy.

Authors:  Francesca Luisa Conforti; Teresa Sprovieri; Rosalucia Mazzei; Carmine Ungaro; Alessandro Tessitore; Gioacchino Tedeschi; Alessandra Patitucci; Angela Magariello; Annalia Gabriele; Vincenzo Labella; Isabella Laura Simone; Giovanni Majorana; Maria Rosaria Monsurrò; Paola Valentino; Maria Muglia; Aldo Quattrone
Journal:  J Negat Results Biomed       Date:  2006-05-29

10.  Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.

Authors:  Claire L Simpson; Robin Lemmens; Katarzyna Miskiewicz; Wendy J Broom; Valerie K Hansen; Paul W J van Vught; John E Landers; Peter Sapp; Ludo Van Den Bosch; Joanne Knight; Benjamin M Neale; Martin R Turner; Jan H Veldink; Roel A Ophoff; Vineeta B Tripathi; Ana Beleza; Meera N Shah; Petroula Proitsi; Annelies Van Hoecke; Peter Carmeliet; H Robert Horvitz; P Nigel Leigh; Christopher E Shaw; Leonard H van den Berg; Pak C Sham; John F Powell; Patrik Verstreken; Robert H Brown; Wim Robberecht; Ammar Al-Chalabi
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

View more
  16 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Importance of diaphragm thickness in amyotrophic lateral sclerosis patients with diaphragm pacing system implantation.

Authors:  Aydın Sanli; Ihsan Sukru Sengun; Kemal Can Tertemiz; Aylin Ozgen Alpaydin; Volkan Karacam; Bahar Agaoglu Sanli; Didem Oz; Sevgi Ozalevli; Nezih Ozdemir
Journal:  Surg Endosc       Date:  2015-03-25       Impact factor: 4.584

3.  Reduced high-frequency motor neuron firing, EMG fractionation, and gait variability in awake walking ALS mice.

Authors:  Muhamed Hadzipasic; Weiming Ni; Maria Nagy; Natalie Steenrod; Matthew J McGinley; Adi Kaushal; Eleanor Thomas; David A McCormick; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

4.  Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes.

Authors:  Janet Cady; Peggy Allred; Taha Bali; Alan Pestronk; Alison Goate; Timothy M Miller; Robi D Mitra; John Ravits; Matthew B Harms; Robert H Baloh
Journal:  Ann Neurol       Date:  2014-11-27       Impact factor: 10.422

5.  Selective degeneration of a physiological subtype of spinal motor neuron in mice with SOD1-linked ALS.

Authors:  Muhamed Hadzipasic; Babak Tahvildari; Maria Nagy; Minjuan Bian; Arthur L Horwich; David A McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 6.  Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.

Authors:  Naoki Suzuki; Ayumi Nishiyama; Hitoshi Warita; Masashi Aoki
Journal:  J Hum Genet       Date:  2022-06-13       Impact factor: 3.172

7.  Motoneuron Diseases.

Authors:  Francesco Lotti; Serge Przedborski
Journal:  Adv Neurobiol       Date:  2022

Review 8.  The neurogenetics of atypical parkinsonian disorders.

Authors:  Brent L Fogel; Mary C Clark; Daniel H Geschwind
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

9.  Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS.

Authors:  Elizabeth Minj; Shubham Upadhayay; Sidharth Mehan
Journal:  Neurochem Res       Date:  2021-06-01       Impact factor: 3.996

10.  ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.

Authors:  Sarah Pickles; Sabrina Semmler; Helen R Broom; Laurie Destroismaisons; Laurine Legroux; Nathalie Arbour; Elizabeth Meiering; Neil R Cashman; Christine Vande Velde
Journal:  Acta Neuropathol Commun       Date:  2016-04-27       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.